1. Coats' disease: Child's vision suddenly affected by rare condition
Missing: Cifariello | Show results with:Cifariello
When nine-year-old Antonio Lulla of Toronto, Ohio, went for his regular wellness visit, he failed his eye exam. Just days before, he was passing a football with his father Steve Lulla. Now, the vision in his left eye was gone.
2. Image of Sophia Loren and Antonio Cifariello in Scandal in Sorrento, Italy,
Italian actor Antonio Cifariello and Italian actress and singer Sophia Loren (Sofia Villani Scicolone) looking into each other eyes in the film Scandal in ...
Download stock image by Reporters Associati & Archivi - Sophia Loren and Antonio Cifariello in Scandal in Sorrento, Italy, 1955 - High quality fine art images, pictures, photos and videos from Bridgeman Images. Experts in licensing art,
3. Gene therapy eyedrops restored a boy's sight. Similar treatments could ...
Missing: Cifariello | Show results with:Cifariello
Short Article
4. RA03401.jpg - akg-images
AKG4051692 Scandal in Sorrento (Pane, amore e...) , 1955, Directed by Dino Risi, Italy, comedy, with Antonio Cifariello ... eyes in the film Scandal in Sorrento.
Sophia Loren and Antonio Cifariello in Scandal in Sorrento
5. Influence of Retinal Vessel Printings on Metamorphopsia and ... - IOVS
We also excluded eyes with reduced vision attributed to other retinal pathologie conditions such as glaucoma and age-related macular degeneration. Finally, ...
Free
6. Correlation of the retinopathy degree with the change of ocular surface ...
May 18, 2021 · To investigate the change of ocular surface and corneal nerve and their correlation in patients suffering from type 2 diabetes mellitus ...
To investigate the change of ocular surface and corneal nerve and their correlation in patients suffering from type 2 diabetes mellitus under different degrees of retinopathy. Totally 129 type 2 diabetes mellitus patients (257 eyes) were included. ...
7. Epi-Off versus Epi-On Corneal Collagen Cross-Linking in ...
F Cifariello. F Cifariello. 1Department of ... Corneal confocal scanning laser microscopy in patients with dry eye disease treated with topical cyclosporine.
To evaluate two different techniques of cross-linking: standard epithelium-off (CXL epi-off) versus transepithelial (CXL epi-on) cross-linking in patient with progressive keratoconus. Forty eyes from 32 patients with progressive keratoconus were ...
8. Cornea: Medical - ESCRS OnDemand
Enrique Antonio Alfonso-Muñoz ... A comparison of three eye solutions with sodium fluorescein to stain the cornea for assisting dry eye disease diagnosis.
Imprint
9. a randomised, double-masked, placebo-controlled Phase IIa study ...
May 28, 2024 · dell'Omo R, Semeraro F, Bamonte G, Cifariello F, Romano MR, Costagliola C. ... Eye diseases · Download PDF. Advertisement. Advertisement. Eye (Eye) ...
To evaluate the safety and efficacy of BI 1467335 in patients with non-proliferative diabetic retinopathy (NPDR). ROBIN is a Phase IIa, double-masked, randomised, placebo-controlled study (NCT03238963). Patients with NPDR and without centre-involved diabetic macular oedema were included; all had a best corrected visual acuity letter score of ≥70 Early Treatment Diabetic Retinopathy Study letters in the study eye at screening. Patients received oral BI 1467335 10 mg or placebo once daily for 12 weeks. Post-treatment follow-up was 12 weeks. The primary endpoint was the proportion of patients over the 24 weeks with ocular adverse events (AEs). Secondary endpoints were the proportion of patients with ≥2-step improvement from baseline in DRSS severity level at Week 12 and the proportion of patients with non-ocular AEs at 24 weeks. Seventy-nine patients entered the study (BI 1467335, n = 40; placebo, n = 39). The proportion of patients with ocular AEs over 24 weeks was greater in the BI 1467335 versus the placebo group (35.0% vs 23.1%, respectively). Treatment-related AEs were reported for similar numbers of patients in the placebo and BI 1467335 group (7.7% vs 7.5%, respectively). At Week 12, 5.7% (n = 2) of patients in the BI 1467335 group had a 2-step improvement in DRSS severity level from baseline, compared with 0% in the placebo group. BI 1467335 was well tolerated by patients with NPDR. There was a high variability in DRSS levels for individual patients over time, with no cl...
